Reformatting historical data and getting scientists to agree on how to generate it are among the biggest hurdles in hybrid ...

Autolomous CEO Alexander Seyf explains why collaboration, not competition, could unlock progress in cell and gene therapy ...

Pharma giant Bayer will invest $2.2B in a New Albany, Ohio manufacturing campus for oncology and cardiovascular drugs, ...

Earlier this month, DaltonTx, an AI company specializing in the biotechnology sector, announced the expansion of its ...

Bio-Techne's new Bristol facility strengthens its cell therapy supply chain with GMP small molecule production, complementing ...

From scale-up pitfalls to tech transfer nightmares, learn how emerging biotech companies can avoid costly mistakes when ...

HPLC continues to meet such demands through advances in column chemistry, instrument performance, and software, allowing laboratories to characterize increasingly complex molecules with greater ...

Helping Downstream Processing To Follow Upstream Innovation. Complex biomolecules place unprecedented demands on conventional ...

Learn strategies for controlling trace metals, polysorbate degradation, and other key formulation risks that can compromise ...

The IND pilot is part of the HHS's ongoing mission to onshore clinical trials.

Rationalizing Biological Drug Development: Biosimilar Science, Modality-Specific Pathways, and the Bioprocessing Revolution, Part 1 Regulatory frameworks for biosimilars were developed two decades ago ...

Examine the use of CHT™ XT Media, a ceramic hydroxyapatite mixed-mode resin, to facilitate purification of various large molecule formats.